142733-66-2 Usage
Uses
Used in Pharmaceutical Research:
Cyclobutanemethanol,3-amino-,cis-(9CI) is utilized as a building block in the synthesis of various organic compounds for pharmaceutical applications. Its unique structure and chemical properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in Chemical Research:
In the field of chemical research, Cyclobutanemethanol,3-amino-,cis-(9CI) serves as a key intermediate for the synthesis of complex organic molecules. Its cyclobutane ring and amino group provide a foundation for further chemical reactions and modifications, contributing to the advancement of chemical science and technology.
Used in Drug Development:
Cyclobutanemethanol,3-amino-,cis-(9CI) is employed as a precursor in drug development, where its structural and chemical features can be leveraged to create novel pharmaceutical agents. Its potential role in the synthesis of bioactive molecules makes it a promising candidate for the discovery and design of new drugs.
Used in Organic Synthesis:
In the realm of organic synthesis, Cyclobutanemethanol,3-amino-,cis-(9CI) is used as a versatile starting material for the preparation of a wide range of organic compounds. Its cyclobutane ring and amino functionality offer opportunities for various synthetic pathways and transformations, expanding the scope of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 142733-66-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,7,3 and 3 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 142733-66:
(8*1)+(7*4)+(6*2)+(5*7)+(4*3)+(3*3)+(2*6)+(1*6)=122
122 % 10 = 2
So 142733-66-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H11NO/c6-5-1-4(2-5)3-7/h4-5,7H,1-3,6H2/t4-,5+
142733-66-2Relevant academic research and scientific papers
CYCLOBUTYL PURINE DERIVATIVE OR SALT THEREOF
-
Paragraph 0250-0252, (2021/05/21)
An object of the present invention is to provide a compound exhibiting an excellent drug efficacy as an anti-adenoviral agent, and an anti-adenoviral agent. The present invention provides a compound represented by General Formula [1] (in the formula, R1 represents a halogen atom, an amino group which may be substituted, a C1-6 alkoxy group which may be substituted, a hydroxyl group which may be protected, or the like; R2 represents a hydrogen atom or an amino protecting group; R3 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like; R4 represents a C1-20 alkoxy group which may be substituted, an aryloxy group which may be substituted, an amino group which may be substituted, or the like); or a salt thereof.
4-CYCLOALKYLAMINOPYRAZOLO PYRIMIDINE NMDA/NR2B ANTAGONISTS
-
, (2010/02/11)
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are effective as NMDA/NR2B antagonists useful for treating neurological conditions such as, for example, pain, Parkinson's disease, Alzheimer's disease, epilepsy, depression, anxiety, ischemic brain injury including stroke, and other conditions.
SYNTHESIS OF NEW CARBOCYCLIC ANALOGUES OF OXETANOCIN A AND OXETANOCIN G
Pecquet, Pascal,Huet, Francois,Legraverend, Michel,Bisagni, Emile
, p. 739 - 745 (2007/10/02)
The synthesis of cis-3-amino-1-cyclobutanemethanol has been performed in six steps (59.6percent yield) from cis-1,3-cyclobutanedicarboxylic anhydride.This allowed us to obtain two new carbocyclic analogues of oxetanocin A and oxetanocin G related to 7-deazaadenosine and 7-deazaguanosine.
